All Resources

Learn about autoimmune type 1 diabetes (T1D) and the importance of early detection through islet autoantibody (IAb) screening. 

Expert interview highlighting the importance and role of C-peptide during the diagnosis and management of type 1 diabetes 

At the BR1DGE symposium at ESPE-ESE 2025, experts discussed the benefits of early detection of people with presymptomatic type 1 diabetes (T1D) and the practical insights from ongoing T1D screening programs.

This article is intended to be a summary only. Additional topics were covered in the live symposium in line with the applicable regulations but are not included on the BR1DGE platform. 

Clear communication about risks, disease stages, and early detection is a key component of successful T1D screening (Prof. Michael Haller). 

Prof. Haller explains that educating caregivers of children with T1D is important so they understand progression risk and the benefits of lifestyle changes.

Prof. Danne explains that widespread implementation of early T1D detection provides a window of opportunity to prepare for and ameliorate the subsequent clinical impact.  

Dr Jeremy Pettus highlights key challenges when identifying adult-onset T1D versus T2D, which can lead to frustration and ineffective management. 

Dr Daniel Agardh discusses the multiple technologies now available for detecting islet autoantibodies associated with type 1 diabetes  

Dr Gun Forsander discusses how AI-powered risk stratification may be utilized to optimize T1D screening strategies 

An infographic describing the prevalence of and challenges faced in diagnosing adult-onset T1D 

Early identification of presymptomatic T1D and subsequent monitoring and education has a range  
of potential benefits 

T1D is a chronic, autoimmune disease with a complex, multifactorial etiology. Explore how genetics and environmental factors can trigger autoimmunity